ArticleScientific reports2025
Detection of antibodies in suspected autoimmune encephalitis diseases using machine learning.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Current and Future Biomarkers in the Diagnosis of Autoimmune Encephalitis: A Review of Biomarker Detection Techniques and Their Performance.Medicina (Kaunas, Lithuania) · 2026Review
- Differential Diagnosis of Infectious Versus Autoimmune Encephalitis Using Artificial Intelligence-Based Modeling.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In our study, we aim to predict the antibody serostatus of patients with suspected autoimmune encephalitis (AE) using machine learning based on pre-contrast T2-weighted MR images acquired at symptom onset. A confirmation of seropositivity is of great importance for a reliable diagnosis in suspected AE cases. The cohort used in our study comprises 98 patients diagnosed with AE. 57 of these patients had previously tested positive for autoantibodies associated with AE. In contrast, no antibodies were detected in the remaining 41 patients. A manual bilateral segmentation of the hippocampus was performed using the open-source software 3D Slicer on T2-weighted MR-images. Subsequently, 107 Radiomics features were extracted from each T2-weighted MR image utilizing the open source PyRadiomics software package. Our study cohort was randomly divided into training and independent test data. Five conventional machine learning algorithms and a neural network were tested regarding their ability to differentiate between seropositive and seronegative patients. All performance values were determined based on independent test data. Our final model includes six features and is based on a Lasso regression. Using independent test data, this model yields a mean AUC of 0.950, a mean accuracy of 0.892, a mean sensitivity of 0.892 and a mean specificity of 0.891 in predicting antibody serostatus in patients with suspected AE. Our results show that Radiomics-based machine learning is a very promising method for predicting serostatus of suspected AE patients and can thus help to confirm the diagnosis. In the future, such methods could facilitate and accelerate the diagnosis of AE even before the results of specific laboratory tests are available, allowing patients to benefit more quickly from a reliable treatment strategy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.